Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean

Dyne Stock Is Up 56%. Here's What a $14 Million Stake Reduction Could Mean

Key PointsFCPM III sold 818,460 shares of Dyne Therapeutics last quarter; the estimated transaction value was $14.11 million based on average prices.Meanwhile, the net position value change of $22.65 million reflects both share sales and quarter-end price movements.The transaction represented a roughly 2% change in the fund’s 13F reportable assets under management (AUM).The post-trade stake stood at 4,644,386 shares valued at $84.20 million.10 s…